Mariner, LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1373442 Overland Park, KS

Position in AMRX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,922,336

-$427,095 QoQ

Shares Held

315,554

-8.6% QoQ

Ownership

0.099%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Mariner, LLC holds $80,494,778 across 23 Drug Manufacturers - Specialty & Generic names. AMRX ranks #7 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	160,869	$21,192,881
2	UTHR	UNITED THERAPEUTICS Corp	27,937	$16,566,080
3	ZTS	Zoetis Inc.	117,842	$13,930,101
4	HLN	Haleon plc	636,787	$6,374,236
5	TAK	Takeda Pharmaceutical Co Ltd	234,988	$4,351,976
6	TEVA	Teva Pharmaceutical Industries Ltd	131,941	$3,974,062
7	AMRX	Amneal Pharmaceuticals, Inc. This page	315,554	$3,922,336
8	RDY	Dr Reddys Laboratories Ltd	221,274	$3,064,644

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,922,336	315,554	-8.6%	Shares	Sole	2026-05-13
2025-12-31	$4,349,431	345,193	-12.6%	Shares	Sole	2026-02-13
2025-09-30	$3,954,850	395,090	-1.1%	Shares	Sole	2025-11-14
2025-06-30	$3,232,043	399,511	+1.5%	Shares	Sole	2025-08-14
2025-03-31	$3,297,722	393,523	-7.3%	Shares	Sole	2025-05-15
2024-12-31	$3,360,384	424,291	+3749.1%	Shares	Sole	2025-02-13
2024-09-30	$91,711	11,023	+4.4%	Shares	Sole	2024-11-13
2024-06-30	$67,017	10,554	+2.9%	Shares	Sole	2024-08-13
2024-03-31	$62,175	10,260	-0.0%	Shares	Sole	2024-05-15
2023-12-31	$62,302	10,264	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.